����������

The Food and Drug Administration the public of the importance of receiving COVID-19 vaccines in accordance to their agency authorizations, a process that FDA said will safely provide the “remarkable” levels of protection observed during large, randomized clinical trials.

Both approved vaccines, of the mRNA type, are approved for administration via two separate doses, given at either three- or four-week intervals.

“The available data continue to support the use of two specified doses of each authorized vaccine at specified intervals,” FDA said.